A randomized control study to compare the efficacy of intranasal fluticasone propionate and intranasal budesonide in controlling postoperative symptoms in patients with nasal polyposis after endoscopic sinus surgery
BACKGROUND. Sinonasal polyposis represents a chronic inflammatory condition characterized by nasal obstruction, reduction in the sense of smell and impaired quality of life. Intranasal steroids play an important role in preventing the postoperative recurrences in these cases. We carried out a study to evaluate and compare intra nasal budesonide and intranasal fluticasone propionate in the postoperative management of ethmoidal nasal polyposis.
MATERIAL AND METHODS. 106 patients with ethmoidal polyposis were treated with endoscopic polypectomy and were postoperatively started and maintained on intranasal steroids. 54 patients were managed with budesonide and 52 patients maintained on fluticasone propionate nasal spray. The patients were followed-up for 6 months and recurrences and control of symptoms evaluated.
RESULTS. There was a statistical difference in the SNOT-22 (p<0.0001) and Lund-Kennedy scores (p=0.015) between patients using fluticasone propionate as compared to those using budesonide intra nasal spray by the end of the 6th month.
CONCLUSION. Both intranasal budesonide and fluticasone propionate are effective in controlling symptoms after endoscopic sinus surgery in patients with sinonasal polyposis; however, intranasal fluticasone propionate was more efficacious than budesonide in the control of postoperative symptoms.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Seiberling KA Kidd SC Kim GH Church CA. Efficacy of dexamethasone versus fluticasone nasal sprays in postoperative patients with chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33(5):478-82. DOI: 10.1177/1945892419841355. Epub 2019 Apr 16.
2. Vaidyanathan S Barnes M Williamson P Hopkinson P Donnan PT Lip-worth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med. 2011;154(5):293-302. DOI: 10.7326/0003-4819-154-5-201103010-00003.
3. Bensch GW. Safety of intranasal corticosteroids. Ann Allergy Asthma Immunol. 2016;117(6):601-5. DOI: 10.1016/j.anai.2016.06.009.
4. Blaiss MS. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc. 2007;28(2):145-52.
5. Aouad RK Chiu AG. State of the art treatment of nasal polyposis. Am J Rhinol Allergy. 2011;25(5):291-8. DOI: 10.2500/ajra.2011.25.3681.
6. Fokkens WJ Lund VJ Mullol J Bachert C Alobid I Baroody F et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1-12. DOI: 10.4193/Rhino50E2.
7. Fandiño M Macdonald KI Lee J Witterick IJ. The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Am J Rhinol Allergy. 2013;27(5):e146-57. DOI: 10.2500/ajra.2013.27.3950.
8. Demoly P. Safety of intranasal corticosteroids in acute rhinosinusitis. Am J Otolaryngol. 2008;29(6):403-13. DOI: 10.1016/j.amjoto.2007.11.004. Epub 2008 Jun 16.
9. Derendorf H Meltzer EO. Molecular and clinical pharmacology of intra-nasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292-300. DOI: 10.1111/j.1398-9995.2008.01750.x.
10. Joe SA Thambi R Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2008;139(3):340–7. DOI: 10.1016/j.otohns.2008.05.628.
11. Rudmik L Schlosser RJ Smith TL Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. Laryngo-scope. 2012;122(7):1431–7. DOI: 10.1002/lary.23259. Epub 2012 Mar 12.
12. Johansson L Holmberg K Melén I Stierna P Bende M. Sensitivity of a new grading system for studying nasal polyps with the potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide). Acta Otolaryngol. 2002;122(1):49-53.
13. Neubauer PD Schwam ZG Manes RP. Comparison of intranasal fluticasone spray budesonide atomizer and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2016;6(3):233-7. DOI: 10.1002/alr.21688. Epub 2015 Dec 17.
14. Huang ZZ Chen XZ Huang JC Wang ZY Li X Chen XH et al. Budesonide nasal irrigation improved Lund-Kennedy endoscopic score of chronic rhinosinusitis patients after endoscopic sinus surgery. Eur Arch Otorhinolaryngol. 2019;276(5):1397-1403. DOI: 10.1007/s00405-019-05327-6. Epub 2019 Feb 20.
15. Holmberg K Juliusson S Balder B Smith DL Richards DH Karlsson G. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol. 1997;78(3):270-6.
16. Vlckova I Navrátil P Kana R Pavlicek P Chrbolka P Djupesland PG. Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device. Rhinology. 2009;47(4):419-26. DOI: 10.4193/Rhin09.024.
17. Holm AF Fokkens WJ Godthelp T Mulder PG Vroom TM Rijntjes E. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol Allied Sci. 1998;23(1):69–73.